RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
IDEAYA Biosciences Stock

IDEAYA Biosciences Employees 2024

IDEAYA Biosciences Employees

43

Ticker

IDYA

ISIN

US45166A1025

WKN

A2PJPB

In 2024, IDEAYA Biosciences employed 43 people, a 0% change from the 43 number of employees in the previous year.

IDEAYA Biosciences Aktienanalyse

What does IDEAYA Biosciences do?

IDEAYA Biosciences Inc is a biotechnology company focused on the development of cancer therapies. The company was founded in 2015 by Yujiro S. Hata and is headquartered in South San Francisco, California. IDEAYA's business model consists of the discovery and development of precision medicine products based on targeted therapies. Targeted therapies are cancer treatments that aim at the specific characteristics of the tumor and have less harmful effects on normal tissue than traditional chemotherapeutics. IDEAYA specializes in the research and development of cancer drugs in three different areas: precision medicine, synthetic lethality, and resistance mechanisms. The company collaborates closely with leading experts in cancer research to develop innovative therapies. In the field of precision medicine, IDEAYA focuses on the development of products based on genetic alterations that cause specific tumors. These genetic alterations are unique to each type of cancer and each individual, meaning that precision medicine products must be individually tailored to each type of cancer. In the area of synthetic lethality, IDEAYA examines the interactions between cancer cells and their environment. These interactions can involve genetic or proteomic changes that make cancer cells dependent on certain signaling pathways and metabolic processes. IDEAYA develops drugs that exploit these dependencies to block the growth of cancer cells. In the area of resistance mechanisms, IDEAYA investigates the mechanisms that cancer cells develop to become resistant to cancer drugs. This involves the discovery of compounds that can bypass these mechanisms and make the cancer cells sensitive to treatments again. IDEAYA has several products in the pipeline, including Inhibat (IDE196) and polyclonal antibodies. Inhibat (IDE196) is a potent and highly selective BRAF inhibitor used in clinical trials for cancer. Polyclonal antibodies are monoclonal antibodies used in cancer immunotherapy. IDEAYA is a company focused on the development of innovative cancer drugs. The company has a solid foundation in cancer research and works closely with leading experts to develop innovative therapies. The company has several products in the pipeline and is working hard to make a significant contribution in cancer research. IDEAYA Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining IDEAYA Biosciences's Employee Base

IDEAYA Biosciences's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding IDEAYA Biosciences's operational capacity and future potential.

Year-to-Year Comparison

Assessing IDEAYA Biosciences's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

IDEAYA Biosciences's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in IDEAYA Biosciences’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about IDEAYA Biosciences stock

How many employees does IDEAYA Biosciences have this year?

IDEAYA Biosciences has 43 undefined employees this year.

How many employees did IDEAYA Biosciences have compared to the previous year?

Compared to the previous year, IDEAYA Biosciences had 0% more employees.

What impact did the number of employees have on the company IDEAYA Biosciences?

The number of employees has a direct impact on the efficiency and productivity of IDEAYA Biosciences. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of IDEAYA Biosciences?

The number of employees can also have an impact on investors of IDEAYA Biosciences, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of IDEAYA Biosciences affect the company?

An increase in equity of IDEAYA Biosciences can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in IDEAYA Biosciences's equity affect the company?

A reduction in equity of IDEAYA Biosciences can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of IDEAYA Biosciences?

Some factors that can influence the equity of IDEAYA Biosciences include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of IDEAYA Biosciences so important for investors?

The equity of IDEAYA Biosciences is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at IDEAYA Biosciences influence the company?

The number of employees at IDEAYA Biosciences can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at IDEAYA Biosciences evolved in recent years?

In recent years, the number of employees at IDEAYA Biosciences has changed by 0.

How many employees does IDEAYA Biosciences currently have?

IDEAYA Biosciences currently has 43 undefined employees.

Why is the number of employees important for investors of IDEAYA Biosciences?

The number of employees is important for investors of IDEAYA Biosciences as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can IDEAYA Biosciences take to change the number of employees?

To change the number of employees, IDEAYA Biosciences can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does IDEAYA Biosciences pay?

Over the past 12 months, IDEAYA Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEAYA Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of IDEAYA Biosciences?

The current dividend yield of IDEAYA Biosciences is .

When does IDEAYA Biosciences pay dividends?

IDEAYA Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IDEAYA Biosciences?

IDEAYA Biosciences paid dividends every year for the past 0 years.

What is the dividend of IDEAYA Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IDEAYA Biosciences located?

IDEAYA Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von IDEAYA Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IDEAYA Biosciences from 8/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/2/2024.

When did IDEAYA Biosciences pay the last dividend?

The last dividend was paid out on 8/2/2024.

What was the dividend of IDEAYA Biosciences in the year 2023?

In the year 2023, IDEAYA Biosciences distributed 0 USD as dividends.

In which currency does IDEAYA Biosciences pay out the dividend?

The dividends of IDEAYA Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IDEAYA Biosciences

Our stock analysis for IDEAYA Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IDEAYA Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.